MMITvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with MMIT, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
MMIT performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/17/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MMIT ETF 2 | -0.30%– | +0.21%– | +1.29%– | +5.82%– | +10.99%– | +5.05%– |
| Flows | MMIT ETF 2 | +$27M– | -$79M– | +$178M– | +$431M– | +$1.01B– | +$1.31B– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MMIT ETF 2 | +1.77%– | +1.86%– | +2.87%– | +2.90%– |
| Max drawdown | MMIT ETF 2 | -0.91%– | -2.49%– | -3.90%– | -12.11%– |
| Max drawdown duration | MMIT ETF 2 | 35d– | 138d– | 127d– | 1153d– |
Trading data
MMIT | ETF 2 | |
Last sale 7/17/2026 at 1:30 PM | $24.20 | – |
| Previous close 07/16/2026 | $24.21 | – |
| Consolidated volume 07/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/17/2026 at 1:30 PM
Live
Closed
MMIT | ETF 2 | |
|---|---|---|
| Last price | $24.20 | – |
| 1D performance | -0.04% | – |
| AuM | $1.48 B | – |
| E/R | 0.48% | – |
Characteristics
MMIT | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | New York Life Investments | – |
| Benchmark | - | – |
| N° of holdings | - | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 18, 2017 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
MMIT
Data will be available soon
ETF 2
Sectors
MMIT
Data will be available soon
ETF 2
Advertisement
Diversification
MMIT
Data will be available soon
ETF 2
–
Top 15 holdings
Data as of January 1, 1970
MMIT
Data will be available soon
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
